High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer
Open Access
- 22 May 2013
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 2 (4), 437-446
- https://doi.org/10.1002/cam4.88
Abstract
Amplification of 8p12-p11 is relatively common in breast cancer and several genes within the region have been suggested to affect breast tumor progression. The aim of the study was to map the amplified 8p12-p11 region in a large set of breast tumors in an effort to identify the genetic driver and to explore its impact on tumor progression and prognosis. Copy number alterations (CNAs) were mapped in 359 tumors, and gene expression data from 577 tumors (359 tumors included) were correlated with CNA, clinical–pathological factors, and protein expression (39 tumors). 8p12-p11 was amplified in 11.4% of tumors. The smallest region of amplification harbored one full-length gene, ZNF703. ZNF703 mRNA expression was significantly higher in estrogen receptor (ER)-positive than ER-negative tumors (P = 2 × 10−16), a reflection of high expression in luminal tumors. Forty-eight percent of tumors with ZNF703 amplification were luminal B tumors in which the best correlation between DNA copy number and mRNA was seen (P = 1.2 × 10−7) as well as correlation between mRNA and protein expression (P = 0.02). High ZNF703 mRNA correlated with poor survival in patients with ER-positive luminal B tumors (log rank P = 0.04). Furthermore, high ZNF703 mRNA expression correlated with poor outcome in patients with ZNF703 copy number neutral, ER-positive, luminal B tumors (log rank P = 0.004). The results support ZNF703 as the driver gene of the 8p12 amplification and suggest that independent of amplification, high expression of the gene affects prognosis in luminal B tumors.Keywords
This publication has 35 references indexed in Scilit:
- Integrated Profiling of Basal and Luminal Breast CancersCancer Research, 2007
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell, 2006
- Multiple Interacting Oncogenes on the 8p11-p12 Amplicon in Human Breast CancerCancer Research, 2006
- Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancersBMC Cancer, 2006
- Comprehensive Profiling of 8p11-12 Amplification in Breast CancerMolecular Cancer Research, 2005
- NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosisOncogene, 2005
- Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genesOncogene, 1999
- Chromosome region 8p11-p21: Refined mapping and molecular alterations in breast cancerGenes, Chromosomes and Cancer, 1998
- FGFRI and PLAT genes and DNA amplification at 8p 12 in breast and ovarian cancersGenes, Chromosomes and Cancer, 1993
- BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers.1991